| 7. A community desires to start a dermatology residency that will be completely funded by a pharmaceutical company. |
| # | Response Date | Comment |
| 1. | Wed, 3/14/07 12:25 AM | depends if that clinic in anyway limits the availbability of other pharma co's products. |
| 2. | Wed, 3/14/07 2:44 AM | It depends on the rights and level of controll that the pharmaceutical company is allowed over the derm residency. If the funds are designed as a public relations move and a tax cut, and they relinquich rights, then there would no COI. The level of control the pharm company retains would/could directly correlate with the level of COI. |
| 3. | Wed, 3/14/07 4:03 PM | On the level of control the pharmaceutical company has. |
| 4. | Wed, 3/14/07 4:45 PM | On whether treatment plans are at all affected/influenced by the pharmaceutical company. |
| 5. | Fri, 3/16/07 2:14 PM | Again, no COI as long as there is full disclosure to the student, patients and community. |